JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pain, S. J.
Right arrow Articles by Peters, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pain, S. J.
Right arrow Articles by Peters, A. M.
Journal of Nuclear Medicine Vol. 43 No. 3 318-324
© 2002 by Society of Nuclear Medicine


Clinical Investigations

Quantification of Lymphatic Function for Investigation of Lymphedema: Depot Clearance and Rate of Appearance of Soluble Macromolecules in Blood

Simon J. Pain, MA1, R. Steven Nicholas, PhD2, Robert W. Barber, MSc2, James R. Ballinger, PhD2, Arnie D. Purushotham, MD1, Peter S. Mortimer, MD3 and A. Michael Peters, MD2

1 Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge, United Kingdom
2 Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom
3 Department of Medicine, St. George’s Hospital Medical School and The Royal Marsden National Health Service Trust, London, United Kingdom

The object of this study was to develop a new technique for the quantitative measurement of lymphatic function. The rate of clearance of radiolabeled protein from a subcutaneous depot is supplemented by measurement of the appearance of the protein in venous blood. This initial study was performed on normal arms, with a view to subsequent clinical application such as in the investigation of women with breast cancer–related lymphedema (BCRL). Methods: Fourteen healthy volunteers (12 women, 2 men) and 8 women awaiting surgery for breast cancer were recruited for the study. Each received subcutaneous depot injection of protein solution in the second dorsal web space of each hand, labeled with 111In on one side and with 99mTc on the other side. Human serum albumin (HSA) was the protein used in the first 8 subjects and human polyclonal immunoglobulin G (HIgG) was used thereafter. The activity at each depot was measured at regular intervals using a collimated sodium iodide scintillation detector, and the activity in venous blood sampled from both arms was measured in an automatic sample counter. Results: 99mTc-HSA cleared from the depot consistently faster than 111In-HSA (P = 0.001). The proportions of radionuclide remaining bound to protein in venous blood were higher for 99mTc than for 111In. HIgG displayed improved labeling stability for both nuclides, reflected in equal rates of clearance. Blood activity rose steadily after an early latent phase and for HIgG correlated strongly with the rate of clearance from the depot (P < 0.001). Marked variation between individuals was observed. Conclusion: A dual-isotope technique relies on identical behavior of the 2 radiopharmaceuticals used. This study shows that this is the case with respect to HIgG but not HSA. 99mTc-HSA cleared faster than 111In-HSA and yet displayed better in vivo labeling stability. We conclude that 111In dissociates from HSA in the depot but then becomes locally bound. Using HIgG, a close correlation was observed between the rates of clearance from the depot and the appearance in venous blood. This finding suggests that HIgG would be a suitable marker for subsequent dual-isotope studies on women with BCRL.

Key Words: lymphatic function • lymphedema • depot clearance




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
K. N. Lane, L. B. Dolan, D. Worsley, and D. C. McKenzie
Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls
J Appl Physiol, September 1, 2007; 103(3): 917 - 925.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Modi, A. W. B. Stanton, W. E. Svensson, A. M. Peters, P. S. Mortimer, and J. R. Levick
Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy
J. Physiol., August 15, 2007; 583(1): 271 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. J. Pain, R. W. Barber, C. K. Solanki, J. R. Ballinger, T. B. Britton, P. S. Mortimer, A. D. Purushotham, and A. M. Peters
Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer
J Appl Physiol, December 1, 2005; 99(6): 2345 - 2351.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. J. Pain, R. W. Barber, J. R. Ballinger, C. K. Solanki, P. S. Mortimer, A. D. Purushotham, and A. M. Peters
Local Vascular Access of Radioprotein Injected Subcutaneously in Healthy Subjects and Patients with Breast Cancer-Related Lymphedema
J. Nucl. Med., May 1, 2004; 45(5): 789 - 796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.